Alzheimer's drug trial halted early: no breakthrough yet
NCT ID NCT06199037
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study tested an experimental drug called SHR-1707 in 46 people with mild memory problems or mild Alzheimer's disease. The goal was to see if the drug could safely reduce harmful protein buildup in the brain. The trial was stopped early, so results are limited and the drug is not available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated hospital of USTC
Hefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.